Subcutaneous Administration of a Zwitterionic Chitosan‐Based Hydrogel for Controlled Spatiotemporal Release of Monoclonal Antibodies (Adv. Mater. 13/2024)

Documenti analoghi

• Landscape of Subcutaneous Administration Strategies for Monoclonal Antibodies in Oncology
  di: Guillaume Jacquot, et al.
  Pubblicazione: (2024)
• Supramolecular Heterodimer Peptides Assembly for Nanoparticles Functionalization (Adv. Healthcare Mater. 15/2024)
  di: Clélia Mathieu, et al.
  Pubblicazione: (2024)
• A single chemotherapy administration induces muscle atrophy, mitochondrial alterations and apoptosis in breast cancer patients
  di: Joris Mallard, et al.
  Pubblicazione: (2024)
• Chemical Production of Cytotoxic Bispecific Antibodies Using the Ugi Multicomponent Reaction
  di: Valentine Vaur, et al.
  Pubblicazione: (2024)
• Nanomaterials Trigger Functional Anti‐Tumoral Responses in Primary Human Immune Cells (Adv. Sci. 39/2025)
  di: Vincent Mittelheisser, et al.
  Pubblicazione: (2025)